Table of Content

Executive Summary
Scope and Definition

1 Markets
1.1 Trends: Current and Future Impact Assessment
1.1.1 Trend 1: Expansion across Therapeutic Areas
1.1.2 Trend 2: Integration with the Healthcare Ecosystem
1.1.3 Trend 3: Utilization of Artificial Intelligence (AI) and Machine Learning (ML) with Digital Therapeutics
1.2 Value Chain Analysis
1.3 Funding Activities
1.4 Regulatory Framework
1.5 Patent Analysis

2 Global Digital Therapeutics Market: Market Dynamics
2.1 Market Drivers
2.2 Market Restraints
2.3 Market Opportunities

3 Global Digital Therapeutic Market (by Product Type)
3.1 Overview
3.2 Growth-Share Matrix
3.3 Product Type Summary
3.4 Software
3.5 Devices

4 Global Digital Therapeutic Market (by Application)
4.1 Overview
4.2 Growth-Share Matrix
4.3 Application Summary
4.4 Treatment/Patient Care-Related Applications
4.4.1 Diabetes
4.4.2 Neurological Disorders
4.4.3 Smoking Cessation
4.4.4 Chronic Respiratory Disorders
4.4.5 Gastrointestinal Disorders
4.4.6 Cardiovascular Diseases
4.4.7 Medication Adherence
4.4.8 Rehabilitation and Patient Care
4.4.9 Others
4.5 Preventive Applications
4.5.1 Nutrition Management
4.5.2 Lifestyle Management
4.5.3 Others

5 Global Digital Therapeutics Market (by Sales Channel)
5.1 Overview
5.2 Growth-Share Matrix
5.3 Sales Channel Summary
5.4 Business-to-Business
5.4.1 Insurance Providers/Corporate Employer
5.4.2 Pharmaceutical Companies
5.4.3 Others
5.5 Business-to-Customer
5.5.1 Patients
5.5.2 Caregivers

6 Global Digital Therapeutics Market (By Region)
6.1 Regional Summary
6.2 North America
6.2.1 Regional Overview
6.2.2 Driving Factors for Market Growth
6.2.3 Factors Challenging the Market
6.2.4 U.S.
6.2.5 Canada
6.3 Europe
6.3.1 Regional Overview
6.3.2 Driving Factors for Market Growth
6.3.3 Factors Challenging the Market
6.3.4 U.K.
6.3.5 Germany
6.3.6 France
6.3.7 Italy
6.3.8 Spain
6.3.9 Rest-of-Europe
6.4 Latin America
6.4.1 Regional Overview
6.4.2 Driving Factors for Market Growth
6.4.3 Factors Challenging the Market
6.4.4 Brazil
6.4.5 Mexico
6.4.6 Rest-of-Latin America
6.5 Asia-Pacific
6.5.1 Regional Overview
6.5.2 Driving Factors for Market Growth
6.5.3 Factors Challenging the Market
6.5.4 China
6.5.5 Japan
6.5.6 India
6.5.7 Australia
6.5.8 South Korea
6.5.9 Rest-of-Asia-Pacific
6.6 Middle East and Africa
6.6.1 Regional Overview
6.6.2 Driving Factors for Market Growth
6.6.3 Factors Challenging the Market
6.6.4 K.S.A.
6.6.5 U.A.E.
6.6.6 Israel
6.6.7 South Africa
6.6.8 Rest-of-Middle East and Africa

7 Markets - Competitive Benchmarking & Company Profiles
7.1 Next Frontiers
7.2 Competitive Analysis
7.3 Global Ecosystem Glimpse
7.4 Geographic Assessment
7.4.1 Akili Interactive Labs, Inc.
7.4.1.1 Overview
7.4.1.2 Top Products/Product Portfolio
7.4.1.3 Recent Developments
7.4.1.4 Top Competitors
7.4.1.5 Target Customers
7.4.1.6 Key Personnel
7.4.1.7 Analyst View
7.4.2 Lark Technologies, Inc.
7.4.2.1 Overview
7.4.2.2 Recent Developments
7.4.2.3 Top Products/Product Portfolio
7.4.2.4 Top Competitors
7.4.2.5 Target Customers
7.4.2.6 Key Personnel
7.4.2.7 Analyst View
7.4.3 2Morrow Inc.
7.4.3.1 Overview
7.4.3.2 Top Products/Product Portfolio
7.4.3.3 Recent Developments
7.4.3.4 Top Competitors
7.4.3.5 Target Customers
7.4.3.6 Key Personnel
7.4.3.7 Analyst View
7.4.4 Click Therapeutics, Inc.
7.4.4.1 Overview
7.4.4.2 Top Products/Product Portfolio
7.4.4.3 Recent Developments
7.4.4.4 Top Competitors
7.4.4.5 Target Customers
7.4.4.6 Key Personnel
7.4.4.7 Analyst View
7.4.5 Biofourmis Inc.
7.4.5.1 Overview
7.4.5.2 Top Products/Product Portfolio
7.4.5.3 Top Competitors
7.4.5.4 Target Customers
7.4.5.5 Key Personnel
7.4.5.6 Analyst View
7.4.6 Glooko, Inc.
7.4.6.1 Overview
7.4.6.2 Top Products/Product Portfolio
7.4.6.3 Recent Developments
7.4.6.4 Top Competitors
7.4.6.5 Target Customers
7.4.6.6 Key Personnel
7.4.6.7 Analyst View
7.4.7 CureApp, Inc.
7.4.7.1 Overview
7.4.7.2 Top Products/Product Portfolio
7.4.7.3 Recent Developments
7.4.7.4 Top Competitors
7.4.7.5 Target Customers
7.4.7.6 Key Personnel
7.4.7.7 Analyst View
7.4.8 Cognoa, Inc.
7.4.8.1 Overview
7.4.8.2 Top Products/Product Portfolio
7.4.8.3 Top Competitors
7.4.8.4 Target Customers
7.4.8.5 Key Personnel
7.4.8.6 Analyst View
7.4.9 Omada Health, Inc.
7.4.9.1 Overview
7.4.9.2 Top Products/Product Portfolio
7.4.9.3 Key Developments
7.4.9.4 Top Competitors
7.4.9.5 Target Customers
7.4.9.6 Key Personnel
7.4.9.7 Analyst View
7.4.10 Cara Care
7.4.10.1 Overview
7.4.10.2 Top Products/Product Portfolio
7.4.10.3 Top Competitors
7.4.10.4 Target Customers
7.4.10.5 Key Personnel
7.4.10.6 Analyst View
7.4.11 Neurotrack Technologies, Inc.
7.4.11.1 Overview
7.4.11.2 Top Products/Product Portfolio
7.4.11.3 Top Competitors
7.4.11.4 Target Customers
7.4.11.5 Key Personnel
7.4.11.6 Analyst View
7.4.12 Kaia Health
7.4.12.1 Overview
7.4.12.2 Top Products/Product Portfolio
7.4.12.3 Key Developments
7.4.12.4 Top Competitors
7.4.12.5 Target Customers
7.4.12.6 Key Personnel
7.4.12.7 Analyst View
7.4.13 ResMed Inc.
7.4.13.1 Overview
7.4.13.2 Top Products/Product Portfolio
7.4.13.3 Key Developments
7.4.13.4 Top Competitors
7.4.13.5 Target Customers
7.4.13.6 Key Personnel
7.4.13.7 Analyst View
7.4.14 Vida Health
7.4.14.1 Overview
7.4.14.2 Top Products/Product Portfolio
7.4.14.3 Key Developments
7.4.14.4 Top Competitors
7.4.14.5 Target Customers
7.4.14.6 Key Personnel
7.4.14.7 Analyst View
7.4.15 Vivante Health, Inc.
7.4.15.1 Overview
7.4.15.2 Top Products/Product Portfolio
7.4.15.3 Key Developments
7.4.15.4 Top Competitors
7.4.15.5 Target Customers
7.4.15.6 Key Personnel
7.4.15.7 Analyst View
8 Research Methodology
8.1 Data Sources
8.1.1 Primary Data Sources
8.1.2 Secondary Data Sources
8.1.3 Data Triangulation
8.2 Market Estimation and Forecast
List of Figures
Figure 1: Global Digital Therapeutics Market (by Region), 2022-2033
Figure 2: Global Digital Therapeutics Market (by Product Type), $Billion, 2022, 2026, and 2033
Figure 3: Global Digital Therapeutics Market (by Application), $Billion, 2022, 2026, and 2033
Figure 4: Global Digital Therapeutics Market (by Sales Channel), $Billion, 2022, 2026, and 2033
Figure 5: Global Digital Therapeutics Market, Recent Developments
Figure 6: Global Digital Therapeutics Market: Value Chain Analysis
Figure 7: Regulatory Framework for Digital Therapeutics
Figure 8: Patent Analysis (by Year), January 2020-November 2023
Figure 9: Patent Analysis (by Country), January 2020-November 2023
Figure 10: Impact Analysis of Market Navigating Factors, 2022-2033
Figure 11: Benefits Offered by Digital Therapeutics
Figure 12: Growth-Share Analysis for Global Digital Therapeutics Market 2022-2033
Figure 13: Growth-Share Analysis for Global Digital Therapeutics Market (by Application), 2022-2033
Figure 14: Growth-Share Analysis for Global Digital Therapeutics Market (by Sales Channel), 2022-2033
Figure 15: U.S. Digital Therapeutics Market, $Billion, 2022-2033
Figure 16: Canada Digital Therapeutics Market, $Billion, 2022-2033
Figure 17: Europe Digital Therapeutics Market, $Billion, 2022-2033
Figure 18: U.K. Digital Therapeutics Market, $Billion, 2022-2033
Figure 19: Germany Digital Therapeutics Market, $Billion, 2022-2033
Figure 20: France Digital Therapeutics Market, $Billion, 2022-2033
Figure 21: Italy Digital Therapeutics Market, $Billion, 2022-2033
Figure 22: Spain Digital Therapeutics Market, $Billion, 2022-2033
Figure 23: Rest-of-Europe Digital Therapeutics Market, $Billion, 2022-2033
Figure 24: Latin America Digital Therapeutics Market, $Billion, 2022-2033
Figure 25: Brazil Digital Therapeutics Market, $Billion, 2022-2033
Figure 26: Mexico Digital Therapeutics Market, $Billion, 2022-2033
Figure 27: Rest-of-Latin America Digital Therapeutics Market, $Billion, 2022-2033
Figure 28: Asia-Pacific Digital Therapeutics Market, $Billion, 2022-2033
Figure 29: China Digital Therapeutics Market, $Billion, 2022-2033
Figure 30: Japan Digital Therapeutics Market, $Billion, 2022-2033
Figure 31: India Digital Therapeutics Market, $Billion, 2022-2033
Figure 32: Australia Digital Therapeutics Market, $Billion, 2022-2033
Figure 33: South Korea Digital Therapeutics Market, $Billion, 2022-2033
Figure 34: Rest-of-Asia-Pacific Digital Therapeutics Market, $Billion, 2022-2033
Figure 35: Middle East and Africa Digital Therapeutics Market, $Billion, 2022-2033
Figure 36: K.S.A. Digital Therapeutics Market, $Billion, 2022-2033
Figure 37: U.A.E. Digital Therapeutics Market, $Billion, 2022-2033
Figure 38: Israel Digital Therapeutics Market, $Billion, 2022-2033
Figure 39: South Africa Digital Therapeutics Market, $Billion, 2022-2033
Figure 40: Rest-of-Middle East and Africa Digital Therapeutics Market, $Billion, 2022-2033
Figure 41: Some of the Key Innovators in Digital Therapeutics Landscape
Figure 42: Key Players in Digital Therapeutics Market (by Application)
Figure 43: Start-Ups in Digital Therapeutics Landscape (by Application)
Figure 44: Global Digital Therapeutics Market: Geographical Assessment
Figure 45: Strategic Initiatives, January 2020-November 2023
Figure 46: Share of Strategic Initiatives
Figure 47: Data Triangulation
Figure 48: Top-Down and Bottom-Up Approach
Figure 49: Assumptions and Limitations
List of Tables
Table 1: Global Digital Therapeutics Market Snapshot
Table 2: Short-Term and Long-Term Opportunities and Risks (by Region)
Table 3: Key Trends, Impact Analysis
Table 4: Some of the Major Funding Scenario in the Global Digital Therapeutics Market
Table 5: Reimbursement Scenario of Some of the Major Countries
Table 6: Global Digital Therapeutics Market (by Product Type), $Billion, 2022-2033
Table 7: Global Digital Therapeutics Market (by Application), $Billion, 2022-2033
Table 8: Global Digital Therapeutics Market (by Treatment/Patient Care-Related Applications), $Billion, 2022-2033
Table 9: Global Digital Therapeutics Market (by Preventive Applications), $Billion, 2022-2033
Table 10: Global Digital Therapeutics Market (by Sales Channel), $Billion, 2022-2033
Table 11: Global Digital Therapeutics Market (by Business-to-Business), $Billion, 2022-2033
Table 12: Global Digital Therapeutics Market (by Business-to-Customer), $Billion, 2022-2033
Table 13: Global Digital Therapeutics Market (by Region), $Billion, 2022-2033
Table 14: Global Digital Therapeutics Market (by Country), $Billion, 2022-2033
Table 15: North America Digital Therapeutics Market (by Product Type), $Billion, 2022-2033
Table 16: North America Digital Therapeutics Market (by Application), $Billion, 2022-2033
Table 17: North America Digital Therapeutics Market (by Treatment/Patient Care-Related Applications), $Billion, 2022-2033
Table 18: North America Digital Therapeutics Market (by Preventive Applications), $Billion, 2022-2033
Table 19: North America Digital Therapeutics Market (by Sales Channel), $Billion, 2022-2033
Table 20: North America Digital Therapeutics Market (by Business-to-Business), $Billion, 2022-2033
Table 21: North America Digital Therapeutics Market (by Business-to-Customer), $Billion, 2022-2033
Table 22: U.S. Digital Therapeutics Market (by Product Type), $Billion,2022-2033
Table 23: U.S. Digital Therapeutics Market (by Application), $Billion, 2022-2033
Table 24: Canada Digital Therapeutics Market (by Product Type), $Billion,2022-2033
Table 25: Canada Digital Therapeutics Market (by Application), $Billion, 2022-2033
Table 26: Europe Digital Therapeutics Market (by Product Type), $Billion, 2022-2033
Table 27: Europe Digital Therapeutics Market (by Application), $Billion, 2022-2033
Table 28: Europe Digital Therapeutics Market (by Treatment/Patient Care-Related Applications), $Billion, 2022-2033
Table 29: Europe Digital Therapeutics Market (by Preventive Applications), $Billion, 2022-2033
Table 30: Europe Digital Therapeutics Market (by Sales Channel), $Billion, 2022-2033
Table 31: Europe Digital Therapeutics Market (by Business-to-Business), $Billion, 2022-2033
Table 32: Europe Digital Therapeutics Market (by Business-to-Customer), $Billion, 2022-2033
Table 33: U.K. Digital Therapeutics Market (by Product Type), $Billion, 2022-2033
Table 34: U.K. Digital Therapeutics Market (by Application), $Billion, 2022-2033
Table 35: Germany Digital Therapeutics Market (by Product Type), $Billion, 2022-2033
Table 36: Germany Digital Therapeutics Market (by Application), $Billion, 2022-2033
Table 37: France Digital Therapeutics Market (by Product Type), $Billion, 2022-2033
Table 38: France Digital Therapeutics Market (by Application), $Billion, 2022-2033
Table 39: Italy Digital Therapeutics Market (by Product Type), $Billion, 2022-2033
Table 40: Italy Digital Therapeutics Market (by Application), $Billion, 2022-2033
Table 41: Spain Digital Therapeutics Market (by Product Type), $Billion, 2022-2033
Table 42: Spain Digital Therapeutics Market (by Application), $Billion, 2022-2033
Table 43: Rest-of-Europe Digital Therapeutics Market (by Product Type), $Billion, 2022-2033
Table 44: Rest-of-Europe Digital Therapeutics Market (by Application), $Billion, 2022-2033
Table 45: Latin America Digital Therapeutics Market (by Product Type), $Billion, 2022-2033
Table 46: Latin America Digital Therapeutics Market (by Application), $Billion, 2022-2033
Table 47: Latin America Digital Therapeutics Market (by Treatment/Patient Care-Related Applications), $Billion, 2022-2033
Table 48: Latin America Digital Therapeutics Market (by Preventive Applications), $Billion, 2022-2033
Table 49: Latin America Digital Therapeutics Market (by Sales Channel), $Billion, 2022-2033
Table 50: Latin America Digital Therapeutics Market (by Business-to-Business), $Billion, 2022-2033
Table 51: Latin America Digital Therapeutics Market (by Business-to-Customer), $Billion, 2022-2033
Table 52: Brazil Digital Therapeutics Market (by Product Type), $Billion, 2022-2033
Table 53: Brazil Digital Therapeutics Market (by Application), $Billion, 2022-2033
Table 54: Mexico Digital Therapeutics Market (by Product Type), $Billion, 2022-2033
Table 55: Mexico Digital Therapeutics Market (by Application), $Billion, 2022-2033
Table 56: Rest-of-Latin America Digital Therapeutics Market (by Product Type), $Billion, 2022-2033
Table 57: Rest-of-Latin America Digital Therapeutics Market (by Application), $Billion, 2022-2033
Table 58: Asia-Pacific Digital Therapeutics Market (by Product Type), $Billion, 2022-2033
Table 59: Asia-Pacific Digital Therapeutics Market (by Application), $Billion, 2022-2033
Table 60: Asia-Pacific Digital Therapeutics Market (by Treatment/Patient Care-Related Applications), $Billion, 2022-2033
Table 61: Asia-Pacific Digital Therapeutics Market (by Preventive Applications), $Billion, 2022-2033
Table 62: Asia-Pacific Digital Therapeutics Market (by Sales Channel), $Billion, 2022-2033
Table 63: Asia-Pacific Digital Therapeutics Market (by Business-to-Business), $Billion, 2022-2033
Table 64: Asia-Pacific Digital Therapeutics Market (by Business-to-Customer), $Billion, 2022-2033
Table 65: China Digital Therapeutics Market (by Product Type), $Billion, 2022-2033
Table 66: China Digital Therapeutics Market (by Application), $Billion, 2022-2033
Table 67: Japan Digital Therapeutics Market (by Product Type), $Billion, 2022-2033
Table 68: Japan Digital Therapeutics Market (by Application), $Billion, 2022-2033
Table 69: India Digital Therapeutics Market (by Product Type), $Billion, 2022-2033
Table 70: India Digital Therapeutics Market (by Application), $Billion, 2022-2033
Table 71: Australia Digital Therapeutics Market (by Product Type), $Billion, 2022-2033
Table 72: Australia Digital Therapeutics Market (by Application), $Billion, 2022-2033
Table 73: South Korea Digital Therapeutics Market (by Product Type), $Billion, 2022-2033
Table 74: South Korea Digital Therapeutics Market (by Application), $Billion, 2022-2033
Table 75: Rest-of-Asia-Pacific Digital Therapeutics Market (by Product Type), $Billion, 2022-2033
Table 76: Rest-of-Asia-Pacific Digital Therapeutics Market (by Application), $Billion, 2022-2033
Table 77: Middle East and Africa Digital Therapeutics Market (by Product Type), $Billion 2022-2033
Table 78: Middle East and Africa Digital Therapeutics Market (by Application), $Billion, 2022-2033
Table 79: Middle East and Africa Digital Therapeutics Market (by Treatment/Patient Care-Related Applications), $Billion, 2022-2033
Table 80: Middle East and Africa Digital Therapeutics Market (by Preventive Applications), $Billion, 2022-2033
Table 81: Middle East and Africa Digital Therapeutics Market (by Sales Channel), $Billion, 2022-2033
Table 82: Middle East and Africa Digital Therapeutics Market (by Business-to-Business), $Billion, 2022-2033
Table 83: Middle East and Africa Digital Therapeutics Market (by Business-to-Customer), $Billion, 2022-2033
Table 84: K.S.A. Digital Therapeutics Market (by Product Type), $Billion, 2022-2033
Table 85: K.S.A. Digital Therapeutics Market (by Application), $Billion, 2022-2033
Table 86: U.A.E. Digital Therapeutics Market (by Product Type), $Billion, 2022-2033
Table 87: U.A.E. Digital Therapeutics Market (by Application), $Billion, 2022-2033
Table 88: Israel Digital Therapeutics Market (by Product Type), $Billion, 2022-2033
Table 89: Israel Digital Therapeutics Market (by Application), $Billion, 2022-2033
Table 90: South Africa Digital Therapeutics Market (by Product Type), $Billion, 2022-2033
Table 91: South Africa Digital Market (by Application), $Billion, 2022-2033
Table 92: Rest-of-Middle East and Africa Digital Therapeutics Market (by Product Type), $Billion, 2022-2033
Table 93: Rest-of-Middle East and Africa Digital Therapeutics Market (by Application), $Billion, 2022-2033
Table 94: Global Digital Therapeutics Market: Ecosystem